MONTREAL,
May 30, 2014 /CNW Telbec/ - Aptilon
Corporation ("Aptilon" or the "Company") (NEX: APZ.H),
reported a net income for the three-month period ended March 31, 2014 of $0.2
million on revenues of $4.8 million compared to a net loss of
$0.8 million on revenues of
$4.1 million for the three-month
period ended March 31, 2013, an
improvement of $1 million.
The Company reported an operating income, before
net finance expense of $0.7 million for the three-month period
ended March 31, 2014 compared to an
operating income, before net finance expense of $0.2 million for the three-month period
ended March 31, 2013.
During the quarter, the Company continued to
improve and expand its data services product offering to
consolidate its position as the communication channel of choice for
healthcare companies to reach professionals through web and mobile
technology.
Complete financial statements and MD&A for
the three-month period ended March 31,
2014 are available on SEDAR at www.sedar.com
About Aptilon Corporation
Aptilon enables pharmaceutical, pharmaceutical marketing companies,
digital advertising agencies and medical device companies to
effectively reach, message, connect and interact with US physicians
and healthcare professionals via multiple access channels. Its
innovative service offerings provide targeted impressions and
interactions through permission-based email, targeted on-line
ad-serving, and mobile app advertising channels. Top pharmaceutical
companies, agencies and respected healthcare organizations have
adopted Aptilon's solutions to target, engage and interact with
leading healthcare practitioners. For more information, visit
www.dmdconnects.com .
Forward-looking statements
This news release contains forward-looking information. These
statements relate to future events or future performance and
reflect management's current expectations and assumptions. Such
forward-looking statements reflect management's current beliefs and
are based on information currently available to management of
Aptilon. A number of factors could cause actual events, performance
or results to differ materially from the events performance and
results discussed in the forward-looking statements. These
forward-looking statements are made as of the date hereof and
Aptilon does not assume any obligation to update or revise them to
reflect new events or circumstances.
Neither NEX, the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Aptilon Holdings